GB9716101D0 - Fused heterocyclic compounds - Google Patents

Fused heterocyclic compounds

Info

Publication number
GB9716101D0
GB9716101D0 GBGB9716101.2A GB9716101A GB9716101D0 GB 9716101 D0 GB9716101 D0 GB 9716101D0 GB 9716101 A GB9716101 A GB 9716101A GB 9716101 D0 GB9716101 D0 GB 9716101D0
Authority
GB
United Kingdom
Prior art keywords
heterocyclic compounds
fused heterocyclic
fused
compounds
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9716101.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Priority to GBGB9716101.2A priority Critical patent/GB9716101D0/en
Publication of GB9716101D0 publication Critical patent/GB9716101D0/en
Priority to JP2000505134A priority patent/JP2001512107A/ja
Priority to AU87317/98A priority patent/AU8731798A/en
Priority to CA002296606A priority patent/CA2296606A1/fr
Priority to PCT/EP1998/004218 priority patent/WO1999006375A1/fr
Priority to EP98938689A priority patent/EP1001941A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GBGB9716101.2A 1997-07-30 1997-07-30 Fused heterocyclic compounds Pending GB9716101D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9716101.2A GB9716101D0 (en) 1997-07-30 1997-07-30 Fused heterocyclic compounds
JP2000505134A JP2001512107A (ja) 1997-07-30 1998-07-02 融合ヘテロ環式化合物及びそのキヌレニン−３−ヒドロキシラーゼ阻害剤としての使用
AU87317/98A AU8731798A (en) 1997-07-30 1998-07-02 Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors
CA002296606A CA2296606A1 (fr) 1997-07-30 1998-07-02 Composes heterocycliques fondus et utilisation de ces composes comme inhibiteurs de la kynurenine-3-hydroxylase
PCT/EP1998/004218 WO1999006375A1 (fr) 1997-07-30 1998-07-02 Composes heterocycliques fondus et utilisation de ces composes comme inhibiteurs de la kynurenine-3-hydroxylase
EP98938689A EP1001941A1 (fr) 1997-07-30 1998-07-02 Composes heterocycliques fondus et utilisation de ces composes comme inhibiteurs de la kynurenine-3-hydroxylase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9716101.2A GB9716101D0 (en) 1997-07-30 1997-07-30 Fused heterocyclic compounds

Publications (1)

Publication Number Publication Date
GB9716101D0 true GB9716101D0 (en) 1997-10-01

Family

ID=10816708

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9716101.2A Pending GB9716101D0 (en) 1997-07-30 1997-07-30 Fused heterocyclic compounds

Country Status (6)

Country Link
EP (1) EP1001941A1 (fr)
JP (1) JP2001512107A (fr)
AU (1) AU8731798A (fr)
CA (1) CA2296606A1 (fr)
GB (1) GB9716101D0 (fr)
WO (1) WO1999006375A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080058515A1 (en) * 2003-07-29 2008-03-06 David Harold Drewry Chemical Compounds
US10065972B2 (en) * 2014-04-23 2018-09-04 Mitsubishi Tanabe Pharma Corporation Bicyclic or tricyclic heterocyclic compound
WO2023077046A1 (fr) 2021-10-29 2023-05-04 Arcus Biosciences, Inc. Inhibiteurs d'hif-2alpha et leurs procédés d'utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
GB9521486D0 (en) * 1995-10-20 1995-12-20 Pharmacia Spa Fluoro-substituted benzoylpropionic acid derivatives
GB9522617D0 (en) * 1995-11-03 1996-01-03 Pharmacia Spa 4-Phenyl-4-oxo-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity

Also Published As

Publication number Publication date
AU8731798A (en) 1999-02-22
WO1999006375A1 (fr) 1999-02-11
CA2296606A1 (fr) 1999-02-11
EP1001941A1 (fr) 2000-05-24
JP2001512107A (ja) 2001-08-21

Similar Documents

Publication Publication Date Title
HUS1600018I1 (hu) Aril kondenzált azapoliciklusos vegyületek
EG24041A (en) New heterocyclic compounds
PL338259A1 (en) Novel spiroazabicyclic heterocyclic compounds
GB9715892D0 (en) Heterocyclic compounds
IL132170A0 (en) Novel heterocyclic compounds
GB9602294D0 (en) Heterocyclic compounds
GB9617305D0 (en) Heterocyclic compounds
ZA981920B (en) Novel heterocyclic compounds
GB9706294D0 (en) Heterocyclic compound
GB9716101D0 (en) Fused heterocyclic compounds
ZA985448B (en) Novel heterocyclic compounds
ZA983800B (en) Novel heterocyclic compounds
EP0900204A4 (fr) Composes heterocycliques
ZA989421B (en) Heterocyclic compounds
GB9715735D0 (en) Heterocyclic compounds
GB9715734D0 (en) Heterocyclic compounds
ZA981177B (en) Heterocyclic compounds
GB9702945D0 (en) Heterocyclic compounds
GB9716378D0 (en) Heterocyclic compounds
GB9801058D0 (en) Heterocyclic compounds
GB9719237D0 (en) Heterocyclic compounds
EP0900219A4 (fr) Composes heterocycliques
EP0900217A4 (fr) Composes heterocycliques
EP0912183A4 (fr) Composes heterocycliques
ZA985449B (en) Novel heterocyclic compounds